Vaccentis Appoints Dr. Ingrid Rauter as Chief Medical Officer and Head of Research & Development
May 03, 2023 03:00 ET
|
Vaccentis AG
Zurich, Switzerland, May 3, 2023 - Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-individualized medicines, today announced the appointment of the experienced life...
Vaccentis strengthens leadership with appointment of Mario Stark as Chief Sales and Marketing Officer
September 08, 2022 02:00 ET
|
Vaccentis AG
Life science executive with experience in ophthalmology, branding, marketing and financingWill lead sales and marketing of medicines for dry eye and autoimmune diseases Zurich, Switzerland,...
Vaccentis stärkt Management durch Berufung von Martin Munte zum CEO
July 12, 2022 02:00 ET
|
Vaccentis AG
Pharmamanager mit langjährige Führungserfahrung bei Amgen, AstraZeneca und RocheWeitere Verstärkung des Managements nach Ernennung dreier neuer Mitglieder im Verwaltungsrat Zurich, Schweiz, 12....
Vaccentis appoints Martin Munte as CEO and strengthens Board
July 12, 2022 02:00 ET
|
Vaccentis AG
Martin Munte has extensive leadership experience at Amgen, AstraZeneca and RocheStrengthening management after appointment of three new Board members Zurich, Switzerland, July 12, 2022 -...